|
|
Name: |
Ghost Tree Capital LLC |
City: |
NEW YORK |
State: |
NY |
Zip: |
10022 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
72 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
AXSM |
Axsome Therapeutics, Inc. |
1 |
- |
$76.54 |
$16,758,000 |
210,000 |
5.39% |
3,626,000 |
45,000 |
0.444 |
N/A |
|
SRPT |
Sarepta Therapeutics Inc |
2 |
- |
$131.38 |
$16,183,000 |
125,000 |
5.2% |
6,540,000 |
25,000 |
0.148 |
Drug Manufacturers - ... |
|
BHVN |
Biohaven Ltd. |
3 |
- |
$37.37 |
$15,587,000 |
285,000 |
5.01% |
3,817,000 |
10,000 |
0.355 |
N/A |
|
MLTX |
Multisys Language Solutions... |
4 |
- |
$0.00 |
$15,069,000 |
300,000 |
4.84% |
10,238,000 |
220,000 |
0.501 |
N/A |
|
ROIV |
Roivant Sciences Ltd. |
5 |
- |
$11.23 |
$13,702,000 |
1,300,000 |
4.4% |
6,964,000 |
700,000 |
0.188 |
N/A |
|
TGTX |
TG Therapeutics Inc |
6 |
- |
$16.48 |
$12,548,000 |
825,000 |
4.03% |
8,278,000 |
575,000 |
0.64 |
Drug Manufacturers - ... |
|
VRDN |
Viridian Therapeutics Ors Shs |
7 |
- |
$13.45 |
$10,944,000 |
625,000 |
3.52% |
4,410,000 |
325,000 |
0.997 |
N/A |
|
TARS |
Tarsus Pharmaceuticals, Inc. |
8 |
- |
$0.00 |
$10,905,000 |
300,000 |
3.51% |
4,830,000 |
0 |
0.906 |
N/A |
|
CRNX |
Crinetics Pharmaceuticals, ... |
9 |
- |
$51.40 |
$9,362,000 |
200,000 |
3.01% |
7,049,000 |
135,000 |
0.272 |
N/A |
|
ALNY |
Alnylam Pharmaceuticals Inc |
10 |
- |
$149.40 |
$8,967,000 |
60,000 |
2.88% |
3,703,000 |
32,500 |
0.049 |
Biotechnology |
|
SLNO |
Soleno Therapeutics Inc |
11 |
- |
$0.16 |
$8,560,000 |
200,000 |
2.75% |
4,037,000 |
87,615 |
0.251 |
N/A |
|
SVRA |
Savara Inc |
12 |
- |
$4.48 |
$7,968,000 |
1,600,000 |
2.56% |
4,443,000 |
850,000 |
1.182 |
Biotechnology |
|
APLS |
Apellis Pharmaceuticals Inc |
13 |
New |
$41.31 |
$7,641,000 |
130,000 |
2.46% |
7,641,000 |
130,000 |
0.114 |
N/A |
|
ISR |
IsoRay, Inc. |
14 |
- |
$1.60 |
$7,140,000 |
6,000,000 |
2.3% |
6,497,000 |
4,400,000 |
10.906 |
Medical Instruments &... |
|
BPMC |
Blueprint Medicines Corp |
15 |
New |
$104.96 |
$6,902,000 |
72,761 |
2.22% |
6,902,000 |
72,761 |
0.11 |
N/A |
|
AVTE |
Aerovate Therapeutics, Inc. |
16 |
- |
$0.00 |
$6,653,000 |
225,000 |
2.14% |
1,901,000 |
15,000 |
0.813 |
N/A |
|
PCVX |
Vaxcyte, Inc. |
17 |
- |
$0.00 |
$6,489,000 |
95,000 |
2.09% |
2,093,000 |
25,000 |
0.088 |
N/A |
|
CABA |
Cabaletta Bio, Inc. |
18 |
- |
$0.00 |
$6,398,000 |
375,000 |
2.06% |
2,993,000 |
225,000 |
0.729 |
N/A |
|
VKTX |
Viking Therapeutics, Inc. |
19 |
- |
$67.00 |
$5,986,000 |
73,002 |
1.92% |
5,986,000 |
73,002 |
0.073 |
N/A |
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
20 |
New |
$37.96 |
$5,416,000 |
125,000 |
1.74% |
5,416,000 |
125,000 |
0.176 |
N/A |
|
BBIO |
Bridgebio Pharma, Inc. |
21 |
- |
$30.09 |
$5,411,000 |
175,000 |
1.74% |
365,000 |
50,000 |
0.101 |
N/A |
|
REPL |
Replimune Group Inc |
22 |
- |
$6.44 |
$5,311,000 |
650,000 |
1.71% |
1,939,000 |
250,000 |
1.059 |
N/A |
|
PHAT |
Phathom Pharmaceuticals, Inc. |
23 |
- |
$0.00 |
$5,151,000 |
485,000 |
1.66% |
1,634,000 |
99,759 |
0.847 |
N/A |
|
ACAD |
Acadia Pharmaceuticals Inc |
24 |
- |
$14.79 |
$4,160,000 |
225,000 |
1.34% |
2,594,000 |
175,000 |
0.14 |
Biotechnology |
|
INSM |
Insmed Inc |
25 |
New |
$24.77 |
$4,070,000 |
150,000 |
1.31% |
4,070,000 |
150,000 |
0.099 |
Biotechnology |
|
TNYA |
Tenaya Therapeutics, Inc. |
26 |
New |
$0.00 |
$4,053,000 |
775,000 |
1.3% |
4,053,000 |
775,000 |
1.211 |
N/A |
|
IMVT |
Immunovant Inc |
27 |
- |
$0.00 |
$4,039,000 |
125,000 |
1.3% |
4,039,000 |
125,000 |
0.144 |
N/A |
|
AGLE |
Aeglea Biotherapeutics, Inc. |
28 |
New |
$0.60 |
$3,793,000 |
100,000 |
1.22% |
3,793,000 |
100,000 |
0.163 |
N/A |
|
SNDX |
Syndax Pharmaceuticals Inc |
29 |
- |
$20.29 |
$3,570,000 |
150,000 |
1.15% |
3,570,000 |
150,000 |
0.16 |
N/A |
|
ENGN |
Engene Holdings Inc. |
30 |
New |
$12.98 |
$3,390,000 |
200,000 |
1.09% |
3,390,000 |
200,000 |
0.862 |
N/A |
|
CGON |
CG Oncology, Inc |
31 |
New |
$29.98 |
$3,293,000 |
75,000 |
1.06% |
3,293,000 |
75,000 |
0.114 |
N/A |
|
GPCR |
Structure Therapeutics Inc. |
32 |
- |
$36.15 |
$3,215,000 |
75,000 |
1.03% |
-2,899,000 |
-75,000 |
0.162 |
N/A |
|
HLXB |
Helix Acquisition Corp. Ii |
33 |
New |
$0.00 |
$3,120,000 |
300,000 |
1% |
3,120,000 |
300,000 |
1.63 |
N/A |
|
COGT |
Cogent Biosciences, Inc. |
34 |
- |
$7.44 |
$3,024,000 |
450,000 |
0.97% |
1,877,000 |
255,000 |
0.475 |
N/A |
|
AQST |
Aquestive Therapeutics, Inc. |
35 |
New |
$3.11 |
$2,995,000 |
702,941 |
0.96% |
2,995,000 |
702,941 |
2.091 |
N/A |
|
DCPH |
Deciphera Pharmaceuticals, ... |
36 |
- |
$25.46 |
$2,777,000 |
176,513 |
0.89% |
-852,000 |
-48,487 |
0.29 |
N/A |
|
TSHA |
Taysha Gene Therapies, Inc. |
37 |
- |
$0.00 |
$2,727,000 |
950,000 |
0.88% |
-990,000 |
-1,150,000 |
0.508 |
N/A |
|
GERN |
Geron Corporation |
38 |
New |
$3.81 |
$2,640,000 |
800,000 |
0.85% |
2,640,000 |
800,000 |
0.147 |
Drug Manufacturers - ... |
|
MRNS |
Marinus Pharmaceuticals Inc |
39 |
- |
$1.33 |
$2,576,000 |
285,000 |
0.83% |
1,109,000 |
150,000 |
0.512 |
N/A |
|
ALT |
Altimmune, Inc |
40 |
New |
$8.01 |
$2,545,000 |
250,000 |
0.82% |
2,545,000 |
250,000 |
0.509 |
Diversified Investments |
|
RGNX |
Regenxbio Inc. |
41 |
New |
$15.99 |
$2,528,000 |
120,000 |
0.81% |
2,528,000 |
120,000 |
0.273 |
N/A |
|
KRYS |
Krystal Biotech Inc |
42 |
- |
$164.10 |
$2,491,000 |
14,000 |
0.8% |
-3,712,000 |
-36,000 |
0.056 |
N/A |
|
KALV |
Kalvista Pharmaceuticals Inc |
43 |
- |
$11.92 |
$2,372,000 |
200,000 |
0.76% |
779,000 |
69,964 |
0.526 |
N/A |
|
NTRA |
Natera, Inc. |
44 |
- |
$106.46 |
$2,287,000 |
25,000 |
0.74% |
95,000 |
-10,000 |
0.022 |
N/A |
|
OLMA |
Olema Pharmaceuticals, Inc. |
45 |
New |
$0.00 |
$2,264,000 |
200,000 |
0.73% |
2,264,000 |
200,000 |
0.363 |
N/A |
|
CRBP |
Corbus Pharmaceuticals Hold... |
46 |
New |
$45.00 |
$2,234,000 |
56,941 |
0.72% |
2,234,000 |
56,941 |
0.045 |
N/A |
|
RVNC |
Revance Therapeutics, Inc. |
47 |
- |
$3.02 |
$2,214,000 |
450,000 |
0.71% |
-1,082,000 |
75,000 |
0.547 |
N/A |
|
PTGX |
Protagonist Therapeutics, Inc |
48 |
- |
$30.74 |
$2,170,000 |
75,000 |
0.7% |
-696,000 |
-50,000 |
0.13 |
N/A |
|
EYPT |
EyePoint Pharmaceuticals Inc |
49 |
- |
$0.44 |
$1,860,000 |
90,000 |
0.6% |
-1,953,000 |
-75,000 |
0.063 |
Biotechnology |
|
MDGL |
Madrigal Pharmaceuticals Inc |
50 |
- |
$220.06 |
$1,736,000 |
6,500 |
0.56% |
-1,735,000 |
-8,500 |
0.033 |
Diagnostic Substances |
|
ARVN |
Arvinas Holding Company, Llc |
51 |
- |
$32.68 |
$1,651,000 |
40,000 |
0.53% |
-788,000 |
-19,250 |
0.058 |
N/A |
|
ATXS |
Astria Therapeutics, Inc |
52 |
- |
$9.54 |
$1,619,000 |
115,000 |
0.52% |
-954,000 |
-220,000 |
0.21 |
N/A |
|
LRMR |
Larimar Therapeutics Inc |
53 |
New |
$1.15 |
$1,598,000 |
210,603 |
0.51% |
1,598,000 |
210,603 |
0.527 |
N/A |
|
CYTK |
Cytokinetics Inc |
54 |
- |
$59.53 |
$1,402,000 |
20,000 |
0.45% |
567,000 |
10,000 |
0.016 |
Biotechnology |
|
CTMX |
Cytomx Therapeutics, Inc. |
55 |
New |
$0.00 |
$1,308,000 |
600,000 |
0.42% |
1,308,000 |
600,000 |
0.921 |
N/A |
|
ELEV |
Elevation Oncology, Inc. |
56 |
New |
$3.61 |
$1,283,000 |
250,000 |
0.41% |
1,283,000 |
250,000 |
0.589 |
N/A |
|
NGNE |
Neurogene |
57 |
New |
$3.68 |
$1,273,000 |
25,000 |
0.41% |
1,273,000 |
25,000 |
0.06 |
N/A |
|
SGMT |
Sagimet Biosciences Inc. |
58 |
New |
$4.62 |
$1,220,000 |
225,000 |
0.39% |
1,220,000 |
225,000 |
1.053 |
N/A |
|
LIFE |
aTyr Pharma Inc |
59 |
New |
$0.37 |
$1,170,000 |
600,000 |
0.38% |
1,170,000 |
600,000 |
1.025 |
N/A |
|
PMVP |
Pmv Pharmaceuticals, Inc. |
60 |
- |
$0.00 |
$1,148,000 |
675,000 |
0.37% |
-1,100,000 |
-50,000 |
1.241 |
N/A |
|
ARWR |
Arrowhead Pharmaceuticals Inc |
61 |
New |
$24.77 |
$1,001,000 |
35,000 |
0.32% |
1,001,000 |
35,000 |
0.034 |
Business Services |
|
RARE |
Ultragenyx Pharmaceutical Inc |
62 |
New |
$41.87 |
$934,000 |
20,000 |
0.3% |
934,000 |
20,000 |
0.024 |
Restaurants |
|
QURE |
uniQure B.V. |
63 |
- |
$5.01 |
$858,000 |
165,000 |
0.28% |
-259,000 |
0 |
0.371 |
N/A |
|
ANTX |
An2 Therapeutics Ord Shs |
64 |
New |
$2.27 |
$713,000 |
219,331 |
0.23% |
713,000 |
219,331 |
0.737 |
N/A |
|
NTLA |
Intellia Therapeutics, Inc. |
65 |
New |
$26.22 |
$688,000 |
25,000 |
0.22% |
688,000 |
25,000 |
0.028 |
N/A |
|
ASND |
Ascendis Pharma AS |
72 |
Closed |
$121.12 |
$0 |
0 |
0% |
-2,519,000 |
-20,000 |
0 |
N/A |
|
AMAM |
Ambrx Biopharma Adr Represe... |
71 |
Closed |
$0.00 |
$0 |
0 |
0% |
-6,764,000 |
-475,000 |
0 |
N/A |
|
ARGX |
Argenx Se |
70 |
Closed |
$365.81 |
$0 |
0 |
0% |
-5,706,000 |
-15,000 |
0 |
N/A |
|
BLUE |
Bluebird Bio, Inc. |
69 |
Closed |
$1.03 |
$0 |
0 |
0% |
-642,000 |
-465,000 |
0 |
Biotechnology |
|
INBX |
Inhibrx, Inc. |
68 |
Closed |
$0.00 |
$0 |
0 |
0% |
-1,330,000 |
-35,000 |
0 |
N/A |
|
CBAY |
Cymabay Therapeutics, Inc. |
67 |
Closed |
$32.48 |
$0 |
0 |
0% |
-2,126,000 |
-90,000 |
0 |
N/A |
|
VRNA |
Verona Pharma Plc |
66 |
Closed |
$0.00 |
$0 |
0 |
0% |
-596,000 |
-30,000 |
0 |
N/A |
|